Solagran has chosen to register Bioeffective^® R in Russia as a new pharmaceutical substance – together with a medicine based on Bioeffective^® R called Ropren^®. Both were registered by the Russian Ministry of Health in July 2007 for the treatment of chronic liver disease.

Summary of Recent Bioeffective^® R and Ropren^® Trials